Call Boomerang Books 1300 36 33 32

Get Latest Book News + FREE Shipping. Subscribe to the Boomerang Books Bulletin eNewsletter right now!

Description - Handbook of Contemporary Neuropharmacology by David R. Sibley

Written and edited by recognized experts, this comprehensive reference is also available online via Wiley InterScience. Provides a readily accessible reference for students, professionals and libraries alike.Editors are recognized authorities in the neuropharmacology and science field.Comprehensive reference text for active junior and senior neurobiologists.Fills an important niche as a text between research publications and clinical applications. The Handbook of Contemporary Neuropharmacology is an invaluable resource for principal investigators and working scientists in academia, government and industry. This three volume set it also of interest for academic physicians, postdoctoral fellows and residents, and all high-level graduate students.

Buy Handbook of Contemporary Neuropharmacology by David R. Sibley from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9780471660538
ISBN-10: 0471660531
Format: Hardback
(260mm x 200mm x 157mm)
Pages: 2992
Imprint: Wiley-Blackwell (an imprint of John Wiley & Sons Ltd)
Publisher: John Wiley and Sons Ltd
Publish Date: 30-Mar-2007
Country of Publication: United Kingdom

Book Reviews - Handbook of Contemporary Neuropharmacology by David R. Sibley

» Have you read this book? We'd like to know what you think about it - write a review about Handbook of Contemporary Neuropharmacology book by David R. Sibley and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)

Write Review


Author Biography - David R. Sibley

DAVID R. SIBLEY, PhD, is a Senior Investigator and Chief of the Molecular Neuropharmacology Section in the National Institute of Neurological Disorders and Stroke, National Institutes of Health. His laboratory is currently investigating the molecular, cellular, and biochemical properties of dopamine receptors and their role in neuronal signaling and pathophysiological states. ISRAEL HANIN, PhD, is Professor and Chair Emeritus in the Department of Pharmacology at Loyola University Chicago. He formerly worked at the National Institute of Mental Health, Laboratory of Preclinical Pharmacology, and at the University of Pittsburgh Department of Psychiatry. Dr. Hanin's research has focused on cholinergic mechanisms, animal models for Alzheimer's disease, and the potential role of glycosaminoglycans in the treatment of Alzheimer's disease. MICHAEL KUHAR, PhD, is currently a Candler Professor and Georgia Research Alliance Professor of Neuropharmacology at the Yerkes Primate Center at Emory University. He previously was a professor in the Neuroscience Department at Johns Hopkins, and a branch chief at the National Institute on Drug Abuse. Dr. Kuhar has published more than 800 articles, abstracts, book chapters, reviews, and patents. PHIL SKOLNICK, PhD, D.Sc. (hon.), is Executive Vice President and Chief Scientific Officer for DOV Pharmaceutical, Inc. He was formerly a Lilly Fellow in Neuroscience and also served as Chief of the Laboratory of Neuroscience, National Institutes of Health.

Books By David R. Sibley